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Influenza A virus infection of vascular endothelial cells induces
GSK-3b-mediated b-catenin degradation in adherens junctions,
with a resultant increase in membrane permeability
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Abstract Multiorgan failure with vascular hyperperme-
ability is the final outcome in the progression of seasonal
influenza virus pneumonia and influenza-associated enceph-
alopathy, and it is also common in infection with highly
pathogenic avian influenza virus. However, the precise
molecular mechanism by which influenza virus infection
causes vascular endothelial cell hyperpermeability remains
poorly defined. We investigated the mechanisms of hyper-
permeability of human umbilical vein endothelial cells
infected with influenza A virus (IAV)/Puerto Rico/8/34 (PR8)
(H1N1). The levels of b-catenin, a key regulatory component
of the vascular endothelial-cadherin cell adhesion complex,
were markedly decreased during infection for 28 h, with
increments of vascular hyperpermeability measured by
transendothelial electrical resistance. Lactacystin (at 2 lM), a
proteasome inhibitor, inhibited the decrease in b-catenin
levels. Since the N-terminal phosphorylation of b-catenin by
glycogen synthase kinase (GSK)-3b is the initiation step of
proteasome-dependent degradation, we examined the effects
of GSK-3b suppression by RNA interference in endothelial
cells. IAV-infection-induced b-catenin degradation was sig-
nificantly inhibited in GSK-3b-knockdown cells, and trans-
fection of cells with recombinant b-catenin significantly
suppressed IAV-induced hyperpermeability. These findings
suggest that IAV infection induces GSK-3b-mediated b-
catenin degradation in the adherens junctional complexes and
induces vascular hyperpermeability. The in vitro findings of
b-catenin degradation and activation of GSK-3b after IAV
infection were confirmed in lungs of mice infected with IAV
PR8 during the course of infection from day 0 to day 6. These
results suggest that GSK-3b-mediated b-catenin degradation
in adherens junctions is one of the key mechanisms of vas-
cular hyperpermeability in severe influenza.
Introduction
Influenza A virus (IAV) is the most common infectious
pathogen in humans and causes significant morbidity and
mortality, particularly in infants and the elderly population
[1, 2]. Multiorgan failure (MOF) with vascular hyperper-
meability is reported in the progressive stage of seasonal
influenza virus pneumonia, particularly in patients with
underlying risk factors [3], and is also common in infec-
tions caused by highly pathogenic avian influenza virus [4].
Vascular hyperpermeability caused by destruction of a
tight junction constituent, zonula occludens-1 (ZO)-1, of
the blood-brain-barrier (BBB) in brain endothelial cells is
also reported in influenza-associated encephalopathy in
infancy and early childhood in East Asians [5–8]. We
reported previously that the ‘‘influenza–cytokine–trypsin
and matrix metalloprotease-9’’ cycle is a key pathogenic
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mechanism in the interaction between IAV infection and
vascular endothelial cells and their hyperpermeability in
severe influenza [8, 9].
The state of hypercytokinemia in IAV infection (e.g., high
levels of tumor necrosis factor, interleukin 6, and interleukin-
1b), called a ‘‘cytokine storm’’, affects cell adhesion, per-
meability, apoptosis, and mitochondrial energy metabolism
and reactive oxygen species, potentially resulting in vascular
dysfunction, hyperpermeability and MOF [10, 11], although
their precise mechanisms have not been elucidated so far.
Furthermore, IAV infection induces upregulation of trypsin
and matrix metalloprotease-9 through an ‘‘influenza–cyto-
kine–protease’’ cycle in various organs and vascular endo-
thelial cells [8, 9, 11, 12], and an increase in the levels of these
proteases in the extracellular space caused by this cycle
results in the degradation of vascular basement membranes
and the extracellular matrix, resulting in vascular hyperper-
meability and inflammatory cell migration. Trypsin promotes
viral entry and replication because IAV does not encode a
viral hemagglutinin processing protease in its own genes, and
post-transcriptional hemagglutinin cleavage by cellular
trypsin-type proteases is needed for membrane fusion activ-
ity, virus entry into cells, and multiple cycles of viral repli-
cation [13–15]. In addition, trypsin evokes cytokine release
via the proteinase-activated receptor (PAR)-2 [16] and also
plays a role in BBB destruction by increasing intracellular
calcium concentrations ([Ca2?]i) and loss of tight-junction
protein ZO-1 via PAR-2 in the BBB [8, 17].
For the control of vascular permeability, there is another
major type of cell-to-cell junction, the adherens junction,
which is ubiquitously distributed along the vascular tree
and is expressed in both blood and lymphatic vessels [18].
The adherens junction is formed by the transmembrane
adhesion molecule vascular endothelial (VE)-cadherin and
its cytoplasmic tail binding molecules, b-catenin and pla-
koglobin, which anchor to actin via a-catenin and stabilize
the junction [19].
In this study, we investigated the mechanisms of IAV-
induced disruption of adherens junctions and vascular
hyperpermeability in human endothelial cells in vitro and
confirmed these findings in vivo. We found that GSK-3b-
mediated b-catenin degradation in the VE-cadherin com-
plex in the adherens junction of human endothelial cells
was associated with increased hyperpermeability after IAV
infection.
Materials and methods
Cell culture
Normal human umbilical vein endothelial cells (HUVECs)
(Kurabo Industries, Osaka, Japan) on type-I-collagen-
coated dishes (10 cm diameter) were grown in HuMedia-
EG2 culture medium using the protocol supplied by the
manufacturer. The cells were cultured in a humidified
atmosphere of 5 % CO2–95 % air gas mixture at 37 C.
Influenza A virus infection
IAV/PR/8/34 (H1N1) was provided by the Research
Foundation for Microbial Diseases of Osaka University
(Kagawa, Japan). Before infection of HUVEC with IAV
PR8, the culture medium was replaced with serum-free
HuMedia-EB2 infection medium containing 0.1 % bovine
serum albumin (BSA). The cells were infected with IAV
PR8 at a multiplicity of infection (MOI) of 1. After incu-
bation for 1 h, the infection medium was replaced with a
culture medium containing various reagents, and the cells
were incubated for another 28 h.
For animal experiments, specified-pathogen-free
4-week-old weanling C57BL/6CrSlc female mice were
obtained from Japan SLC and maintained in a 12-h light/
dark cycle in a temperature-controlled room with free
access to food and water. All animals were treated
according to the Guide for the Care and Use of Laboratory
Animals (NIH Publication No. 85-23, 1996), and the study
was approved by the Animal Care Committee of the Uni-
versity of Tokushima. Under ketamine and xylazine anes-
thesia, 100 plaque-forming units of IAV PR8 in 20 lL of
saline or saline alone as an uninfected control was instilled
intranasally in mice. Body weight and survival were
monitored daily, and the animals were assessed visually for
signs of clinical disease including inactivity, ruffled fur,
labored respiration and huddling behavior. Mice that lost
C30 % of their original body weight and/or displayed
evidence of pneumonia were sacrificed by overdose of
intraperitoneal ketamine and xylazine. These experiments
were conducted under animal BSL2 conditions.
Western immunoblotting
HUVECs after various treatments were lysed in radioim-
munoprecipitation assay (RIPA) buffer (50 mM Tris-HCl,
pH 8.0, 150 mM NaCl, 10 % glycerol, 1 % NP 40, 0.5 %
deoxycholate, 0.4 mM EDTA, and 0.5 mM sodium ortho-
vanadate) for 30 min at 4 C. Mouse lungs isolated during
the course of IAV infection (from day 0 to day 6) were
homogenized with five volumes of RIPA buffer. Cell lysate
and lung homogenate were centrifugation at 10,0009g for
30 min. The prepared cell lysates (20 lg protein/lane) and
lung extracts (20 lg protein/lane) were separated by
sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE) using 10-to-20 % gradient gel and trans-
ferred onto an Immobilon-P membrane (Millipore, Bed-
ford, MA). After blocking with 5 % non-fat milk in 20 mM
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Tris-HCl, pH 7.5, 150 mM NaCl and 0.05 % Tween 20,
the membranes were incubated with optimal primary
antibodies for 2 h. The primary antibodies included anti-b-
catenin, anti-VE-cadherin, anti-b-actin and anti-glycogen
synthase kinase (GSK)-3b (all from Santa Cruz Biotech-
nology, Santa Cruz, CA), anti-phospho-GSK-3b (Ser9)
(Cell Signaling Technology, Beverly, MA) and anti-IAV
(Takara). Thereafter, peroxidase-conjugated anti-mouse
(Invitrogen, Carlsbad, CA), -rabbit (Sigma, St. Louis, MO)
or -goat (Sigma) IgG antibodies were incubated for 30 min,
followed by enhanced chemiluminescence reagents (GE
Healthcare Biosciences, Uppsala, Sweden) for 1 min.
Reverse transcription polymerase chain reaction
(RT-PCR)
Total RNA was extracted from HUVECs using an RNeasy
Mini Kit (QIAGEN, Hilden, Germany). RT-PCR was
carried out using a One-Step RT-PCR Kit (QIAGEN)
according to the instructions provided by the manufacturer.
To amplify the PCR product of b-catenin, the following
primer pair was used (forward primer, 50-TTTGGCTGAA
CCATCACAGA-30; and reverse primer, 50-TGTTGAG
CAAGGCAACCATT-30). The products were examined by
agarose gel electrophoresis after 25 cycles.
Relative quantitation analysis
Protein or mRNA bands detected on X-ray films or pictures
were calculated by densitometric analysis using Just TLC
(Sweday, Lund, Sweden). The relative levels of the
immunoblot or RT-PCR bands were expressed as mean
values ±SD.
RNA interference
The sequence of the sense strand used to generate specific
siRNA was obtained as follows: GSK-3b, NCBI Reference
Sequence: NG_012922.1, 50-AAATCTCTTGTCCTGCA
ATAC-30. A small interfering RNA (siRNA) was synthe-
sized using a Silencer siRNA Construction Kit (Ambion,
Austin, TX) according to the instructions supplied by the
manufacturer. HUVECs were transfected with the siRNA
at 10 nM, using Oligofectamine Transfection Reagent
(Invitrogen) and grown for 72 h to allow sufficient
decrease in the expression of this molecule.
Assessment of hyperpermeability by trans-endothelial
electrical resistance (TEER) and transfection
with recombinant b-catenin
HUVEC were plated in the upper chamber of type I col-
lagen-coated cell culture inserts with a membrane of
3.0 lm pore size. After infection of the cells with IAV PR8
at a MOI of 1 for 24 h, some of the cells on the plates were
transfected with recombinant b-catenin (1.2 lg/mL) (Mil-
lipore). Recombinant b-catenin was exposed to the trans-
fection reagent TransIT-LT1 polyamine (Mirus, Madison,
WI) for 15 min before transfection. After transfection for
4 h, the TEER across monolayers of endothelial cells was
measured using Millicell-ERS (Millipore) using the
method described previously [20, 21]. The electrical
resistance of blank inserts containing the medium only was
subtracted from the TEER measurements made from
inserts containing confluent endothelial cell monolayers.
Statistical analysis
The mean values ±SD of individual groups were calcu-
lated, and the differences between groups were analyzed
using the unpaired t-test or multiple comparisons (Bon-
ferroni or Dunnett tests) after one-way analysis of variance
(ANOVA). All statistical analyses were performed using
Microsoft Excel (Microsoft, Redmond, WA) add-in Ekus-
eru-Toukei 2010 version 1.10 (Social Survey Research
Information Co.). All values are two-tailed and those less
than 0.05 were considered statistically significant.
Results
IAV infection downregulates b-catenin significantly,
but not VE-cadherin, in adherens junctional proteins
in HUVECs
Figures 1A and B show the results of immunoblotting
analyses of b-catenin and VE-cadherin, the major adherens
junctional proteins, in HUVECs infected with IAV PR8 at
an MOI of 1 for 28 h or in uninfected cells. Infection sig-
nificantly suppressed the expression of b-catenin to 24 % of
the no-infection control (P \ 0.0001). The expression of
the transmembrane adhesive component VE-cadherin also
tended to decrease, though not significantly, after infection
(P = 0.2472). Quantitative RT-PCR analysis showed a
slight, but significant, decrease in the b-catenin mRNA
level to 84 % of the no-infection control (P = 0.0188) in
infected HUVECs (Fig. 1C and D). The discrepancy
between the suppression levels of b-catenin protein and
those of b-catenin mRNA after IAV infection indicates that
the marked suppression of the b-catenin protein level was
probably due to enhanced b-catenin protein degradation.
Lactacystin inhibits IAV-induced b-catenin degradation
To verify the above-stated findings, HUVECs were treated
with 2 lM lactacystin (Sigma), a proteasome inhibitor
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[22], at the time of PR8 infection and the cells were
incubated for 28 h. Under no-infection conditions, lacta-
cystin did not affect b-catenin protein levels in HUVEC
(P = 1.0000) (Fig. 2A and B). In contrast, lactacystin
significantly abrogated the suppression of the b-catenin
protein level in IAV PR8-infected HUVECs (P = 0.0207),
and the levels were 1.8-fold higher than those in infected
cells that were not treated with lactacystin. The inhibitory
effect of lactacystin was dose-dependent, and lactacystin at
0.5 lM was not enough to restore the b-catenin levels
(Fig. 2C). Expression of VE-cadherin was not affected by
treatment with various doses of lactacystin. These results
confirmed that the downregulation of the b-catenin protein
level in IAV PR8-infected HUVECs is the result of
enhanced proteasomal degradation.
IAV PR8 infection activates GSK-3b in HUVECs
b-Catenin, which is phosphorylated by GSK-3b at residues
37 and 33, is recognized by the b-TrCP E3-ligase com-
plex, ubiquitylated, and rapidly degraded by the 26S pro-
teasome [23, 24]. To elucidate the mechanism(s) of
enhanced b-catenin degradation in HUVEC by IAV
infection, the expression level of the active form of
dephosphorylated GSK-3b (Ser9) was analyzed by western
immunoblotting using specific antibodies against GSK-3b
and phospho-GSK-3b (Ser9) to detect the inactive form of
phosphorylated GSK-3b (Fig. 3A and B). The total
amount of GSK-3b in IAV PR8-infected cells was only
Fig. 1 Infection with IAV reduces the expression of b-catenin in
adherens junctional proteins in HUVECs. A. Representative immu-
noblot (from three separate experiments) of b-catenin and VE-
cadherin in cell lysates (20 lg protein/lane) of HUVECs after
infection for 28 h with or without IAV PR8. As a control, saline
was used as no-infection agent. B. Relative levels of b-catenin and
VE-cadherin in the blot in panel A (n = 3), determined as described
in Materials and methods. Statistical analysis was performed using the
unpaired t-test. C. Representative RT-PCR data of b-catenin in
control (uninfected) and IAV-infected HUVECs at 28 h post-trans-
fection. D: Relative levels of b-catenin in the RT-PCR experiment
shown in panel C (n = 3). Statistical analyses were conducted using
the unpaired t-test
Fig. 2 Lactacystin inhibits IAV-induced b-catenin suppression. A.
Representative immunoblot (from three separate experiments) of b-
catenin in cell lysates (20 lg protein/lane) of control (uninfected) or
IAV-infected HUVECs treated with or without lactacystin for 28 h.
B. Relative level of b-catenin in the blot in panel A (n = 3). Multiple
comparisons tests (Bonferroni test after one-way analysis of variance
(ANOVA) were used for statistical analysis. C. Dose-response effect
of lactacystin on b-catenin and VE-cadherin expression. HUVECs
were treated with various concentrations of lactacystin (from 0 to
2 lM) at the time of infection and then incubated for 28 h. A
representative immunoblot of b-catenin and VE-cadherin in cell
lysates (20 lg protein/lane) with or without infection is shown
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slightly decreased to 83 % of the no-infection control
cells, and the decrease was not significant (P = 0.3553).
In contrast, IAV infection markedly decreased the level of
the phosphorylated-GSK-3b (Ser9) form to 8 %
(P = 0.0035). These results indicate that IAV infection
induces GSK-3b in HUVECs from the inactive phos-
phorylated-GSK-3b (Ser9) form to the active dephospho-
rylated-GSK-3b (Ser9) form.
GSK-3b knockdown protects against IAV infection-
induced suppression of b-catenin expression
Since degradation of b-catenin, a major component of the
VE-cadherin complex, is initiated by the activation of
GSK-3b, we next analyzed the effects of GSK-3b gene-
silencing on the level of b-catenin in IAV-infected and
uninfected HUVECs (Fig. 4A and B). HUVECs treated
with or without GSK-3b knockdown were infected with
IAV PR8 at a MOI of 1 and b-catenin levels in the cells
were measured by western immunoblotting at 28 h post-
infection. Under no-infection conditions, GSK-3b knock-
down treatment resulted in suppression of GSK-3b
expression in HUVEC to about 20 % of the level without
treatment. Although GSK-3b expression was downregu-
lated in HUVECs by IAV infection, the expression was
further suppressed by GSK-3b gene silencing to an unde-
tectable level. The b-catenin expression level in HUVECs
treated with GSK-3b knockdown under no-infection con-
ditions was 76 % of those without knockdown treatment
(P = 0.0126). However, the b-catenin expression level in
GSK-3b knockdown cells was 1.9-fold of that in HUVECs
without treatment under infection conditions (P = 0.0002).
These data suggest that the b-catenin level in the VE-
cadherin complex is strictly regulated by GSK-3b in IAV-
infected HUVECs.
Transfection with b-catenin restores the IAV-infection-
disrupted barrier function
The hyperpermeability of monolayers of HUVECs was
measured by TEER. Infection of HUVECs with IAV PR8
at an MOI of 1 for 24 h resulted in a significant decrease in
TEER (P = 0.0367), indicating cell hyperpermeability
(Fig. 5). Transfection of the vehicle (TransIT-LT1 poly-
amine) tended to reduce TEER, albeit insignificantly
(P = 0.5409). However, pretreatment of HUVECs by
transfection with recombinant b-catenin for 4 h markedly
increased TEER (P = 0.0003), and the monolayer
Fig. 3 IAV infection induces suppression of phosphorylated GSK-3b
in HUVECs. A. Representative immunoblots (from three separate
experiments) of total GSK-3b and phosphor-GSK-3b (Ser9) in cell
lysates (20 lg protein/lane) of control (uninfected) or IAV-infected
HUVECs. B. Relative levels of total GSK-3b and phosphor-GSK-3b
(Ser9) in the blot in panel A (n = 3). Data are mean ± SD. Statistical
analyses were conducted using the unpaired t-test
Fig. 4 GSK-3b knockdown protects against IAV-induced suppres-
sion of b-catenin. A. Representative immunoblots (from three
separate experiments) of GSK-3b and b-catenin in cell lysates
(20 lg protein/lane) of HUVECs pre-treated with or without GSK-3b
knockdown under control (no-infection) and IAV-infection condi-
tions. B. Relative levels of GSK-3b and b-catenin in the bolt in panel
A (n = 3). Differences between groups were analyzed using the
unpaired t-test
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permeability was almost completely restored to the levels
recorded in uninfected and untransfected cells.
Changes in expression levels of adherens junctional
proteins and GSK-3b in lungs of mice infected
with IAV PR8
The time courses of change in b-catenin, VE-cadherin,
GSK-3b, phospho-GSK-3b (Ser 9) and viral nucleoprotein
(NP) expression levels were analyzed in the lungs of mice
infected intranasally with IAV PR8 at 100 PFU from day 0
to day 6. The average body weight of infected mice started
to fall at day 3 postinfection and an approximately 26 %
loss relative to the original weight was observed on day 6,
but the average body weight of uninfected mice showed a
continuous increase (Fig. 6A1). All animals survived dur-
ing the experimental period except one infected animal,
which died on day 6.
The viral NP levels in the lungs monitored by western
immunoblotting showed that they started to increase at day
2 postinfection, reaching a peak at day 3 and then gradually
decreasing (Fig. 6A2). Progressive and marked downreg-
ulation of b-catenin was noted during the infection period
from day 2 to day 6 (Fig. 6B and C). This was coupled with
simultaneous downregulation of phosphor-GSK-3b (Ser 9)
(inactive form) expression in the lungs, and marked
downregulation began at day 1 postinfection and persisted
until day 6 postinfection. In contrast to these changes, total
GSK-3b expression was steady until day 4 postinfection
and was significantly upregulated at day 6. A mild and
continuous decrease in the expression of VE-cadherin was
detected until day 3 post-expression, followed by a marked
decrease in expression from day 4 to day 6 postinfection.
Changes in these expression levels were observed in the
lungs at day 6 postinfection, the starting point of an
obvious multi-organ failure phase with vascular hyperper-
meability [15]. These in vivo changes in lung tissue added
support to the in vitro findings of increased hyperperme-
ability after infection of HUVECs with IAV PR8.
Discussion
The present study resulted in several new findings: (i) IAV
PR8 infection markedly decreased the level of a regulatory
component of the VE-cadherin cell adhesion complex, b-
catenin, in association with enhanced permeability of
human vascular endothelial cells. (ii) The decrease in b-
catenin protein levels in the cells was the result of degra-
dation by activation of GSK-3b, and the degradation was
inhibited by lactacystin, a proteasome inhibitor. (iii) IAV
infection-induced b-catenin degradation was suppressed in
HUVECs by GSK-3b knockdown and restoration of cel-
lular barrier function by transfection with b-catenin. (iv)
There was marked downregulation of adherens junctional
protein b-catenin and upregulation of dephosphorylated
GSK-3b (active GSK-3b) in the lungs of mice infected
with IAV PR8.
Until recently, anti-influenza agents that inhibit viral
replication have represented the best treatment option.
However, MOF appears just after influenza virus peak
proliferation with the initiation of host immune responses
and development of metabolic disorders [11, 15], and thus
the use of antiviral neuraminidase inhibitors is not suitable
for the treatment of MOF after viral proliferation. MOF
induced by severe IAV infection is the final outcome of
circulatory failure, hypoxemia, and vascular hyperperme-
ability of endothelial cells through the ‘‘influenza–cyto-
kine–trypsin and matrix metalloprotease-9’’ cycle [8, 11],
with disruption of vascular junctions. In a series of studies,
we reported previously that upregulation of trypsin in brain
vascular endothelial cells by pro-inflammatory cytokines
after IAV infection plays a pivotal role in the destruction of
tight junctions in the BBB through an increase in [Ca2?]i
and loss of ZO-1 via proteinase-activated receptor-2 sig-
naling [8, 17].
Adherens junction, another major type of junction in the
vascular endothelium, plays important roles in contact
inhibition of endothelial cell growth and paracellular per-
meability to circulating leukocytes and solutes. Adherens
junctions are ubiquitously distributed, and endothelial cells
Fig. 5 Transfection with recombinant b-catenin abrogates IAV
infection-induced impairment of barrier function. TEER data across
monolayers of control (uninfected) and IAV-infected HUVECs
(n = 6), and with or without recombinant b-catenin transfection
were analyzed using multiple comparison (Bonferroni test) after one-
way analysis of variance (ANOVA)
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Fig. 6 b-Catenin suppression and GSK-3b activation in lungs of
IAV-infected mice. A1, change in body weight of infected and
uninfected mice (five mice in each group). A2, change in viral NP
levels in the lungs monitored by western immunoblotting (B). One
infected animal died on day 6 postinfection. The values represent the
mean ± SD of five or four mice. B and C, Data represent the
expression levels (B) and relative quantified data (C) of b-catenin,
VE-cadherin, GSK-3b, and phospho-GSK-3b (Ser9) in lung extracts
(20 lg protein/lane) of control (no-infection) and IAV-infected mice
from day 1 to day 6 postinfection. C.S., calibration standard (mixture
of uninfected sample except for NP analysis) to normalize the
intensity of protein bands in different gels. As the C.S. for NP, a
sample from one animal after infection for 4 days was used. b-Actin
was used as an internal control. Data are representative of three
separate experiments. Multiple comparison (Dunnett test) after
ANOVA were used for statistical analysis. P-values are relative to
the control (no infection)
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in all types of blood vessels express VE-cadherin. The
cytoplasmic tail of VE-cadherin binds b-catenin and pla-
koglobin at the carboxy-terminal region, both of which link
a-catenin and anchor the complex to the actin cytoskeleton
[18]. The first of these, b-catenin is a major regulatory
component of the VE-cadherin-b-catenin adhesive com-
plex, and its level is tightly regulated by GSK-3b, followed
by the phosphorylation-dependent ubiquitin-proteasome
degradation pathway in a manner similar to the phos-
phorylation-dependent degradation of IjB [23].
As an extension to our previous studies on the mecha-
nisms of vascular hyperpermeability in MOF caused by
severe IAV infection, we studied the mechanisms of
destruction of the VE-cadherin-b-catenin adhesive com-
plex and vascular hyperpermeability after IAV infection in
human endothelial cells, both in vitro and in vivo. Our
results showed marked b-catenin degradation by protea-
somes and a significant decrease in phosphorylated GSK-
3b (Ser9) expression in HUVECs after IAV infection
(Figs. 1, 3 and 6). The findings of downregulation of b-
catenin after IAV infection through the activation of GSK-
3b followed by the phosphorylation-dependent ubiquitin-
proteasome degradation pathway were supported by the
experiments of GSK-3b gene silencing. GSK-3b-gene-
silenced HUVECs showed almost complete protection
against b-catenin downregulation in cells infected with
IAV (Fig. 4), and b-catenin degradation was inhibited by
lactacystin (Fig. 2). In addition, expression of recombinant
b-catenin in HUVECs almost completely restored mono-
layer hyperpermeability induced by IAV infection. These
results indicate that the level of b-catenin in the VE-cad-
herin-b-catenin adhesive complex is important for regula-
tion of vascular permeability and that the b-catenin level is
regulated by the GSK-3b-mediated b-catenin degradation
pathway. The findings with IAV-infected HUVECs support
previous studies on b-catenin degradation in the absence of
Wingless/Wnt signaling pathway via GSK-3b-mediated b-
catenin phosphorylation and the phosphorylation-depen-
dent ubiquitin-proteasome degradation pathway in various
mammalian cells [23].
The mitochondria-mediated caspase activation pathway
is a major apoptotic pathway characterized by mitochon-
drial outer membrane permeabilization [24], and degrada-
tion of b-catenin by caspase-3 in the signaling pathway of
apoptosis is another major contributing factor to tissue and
cell damage, including hyperpermeability of endothelial
cells [25–28]. We reported previously that IAV infection
induces hyperpermeability associated with mitochondrial
dysregulation, calcium mobilization, and loss of ZO-1 via
protease-activated receptor in HUVECs [8] and apoptosis
via mitochondrial membrane depolarization in cardiomyo-
blasts [9]. Upregulated TNF-a also induces mitochondrial
Fig. 7 Diagram illustrating the
proposed mechanism of
disruption of the adherens
junctional complexes of
vascular endothelial cells after
severe IAV infection. Infection
of vascular endothelial cells
with IAV decreases b-catenin in
the VE-cadherin-b-catenin
adhesive complex by activation
of GSK-3b and the
phosphorylation-dependent
ubiquitin-proteasome
degradation pathway. TLR,
Toll-like receptor; dsDNA,
double-stranded DNA; ssRNA,
single-stranded RNA. The
question mark indicates that
signal transductions between
TLRs and GSK-3b are
unidentified
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dysregulation through increasing mitochondrial O2
- pro-
duction and depleting ATP synthesis, decreasing oxygen
consumption [10, 29], and increasing [Ca2?]i [30].
GSK-3b is a serine/threonine protein kinase that has
been shown recently to play a key role during the
inflammatory response induced by various pathogenic
bacteria, such as Francisella tularensis, the causative
agent of highly virulent tularemia [31], Burkholderia
pseudomallei [32] and group A streptococcus [33]. Bac-
terial lipopolysaccharides and lipid A are recognized by
the Toll-like receptor (TLR)-2 on the cellular membrane
and regulate GSK-3b activity via a phosphoinositide
3-kinase-Akt-dependent pathway [31]. In the present
study, we found GSK-3b activation-mediated b-catenin
degradation and monolayer hyperpermeability in IAV-
infected HUVECs, and we propose a mechanism for the
disruption of the adherens junctional complexes of vas-
cular endothelial cells after severe IAV infection (Fig. 7).
Since TLR2 and TLR4 bind to viral structural protein with
CD14 [34], TLR7/8 binds to ssRNA and TLR3 binds to
dsRNA [17], further studies on IAV-induced signal
transduction from TLRs to GSK-3b activation are needed.
In addition, there is also a need to design new therapeutic
agents that can upregulate b-catenin and inhibit GSK-3b
in vascular endothelial cells.
In summary, our results show that infection of HUVECs
with IAV PR8 markedly decreases b-catenin levels in the
VE-cadherin-b-catenin adhesive complex of HUVECs,
together with hyperpermeability of HUVEC monolayers.
The level of b-catenin in the adhesive complex is tightly
regulated by activation of GSK-3b and the phosphoryla-
tion-dependent ubiquitin-proteasome degradation pathway.
Destruction of the VE-cadherin-b-catenin adhesive com-
plex could be one of the main pathomechanisms of MOF
after severe IAV infection.
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